what happens when you switch from semaglutide to tirzepatide Switching Tirzepatide: to Expect — Affinity Whole Health switch tirzepatide to semaglutide is

Just like medications for blood pressure or cholesterol, semaglutide treats an ongoing biological condition

NAION, or nonarteritic anterior ischemic optic neuropathy, can cause irreversible vision loss

Clinical trial data demonstrate that patients typically regain a substantial portion of lost weight after stopping treatment

And even the two largest beverage companies, Coca-Cola and PepsiCo, are planning prebiotic launches for 2025, despite previously downplaying the impact of weight-loss drugs on their bottom lines.

Wegovy (semaglutide 2.4 mg) is a prescription-only glucagon-like peptide-1 (GLP-1) receptor agonist licensed in the UK for weight management in adults with obesity or overweight with weight-related comorbidities